Astellas was founded in 2005 through the merger of Yamanouchi and Fujisawa, combining nearly two centuries of collective experience to create an international pharmaceutical company with innovation for patients at its heart.
As a global pharmaceutical company with its own distribution channels in more than 50 countries around the world, Astellas is developing business in a well-balanced manner across its four main regions of Japan, the Americas, EMEA and Asia & Oceania.
On the forefront of healthcare change, Astellas is committed to turning innovative science into medical solutions that bring value and hope to patients worldwide.
We understand that patients, caregivers, healthcare professionals and others in our industry face great challenges, and patient needs for medical advancements remain urgent.
We work with a range of industry and charitable organisations to improve access to health, contribute to the world’s development and respond to the growing healthcare challenges of a global society. We are passionate about Corporate Social Responsibility initiatives that create sustainable, long-term benefit for patients and communities around the world.
At Astellas, we are committed to the ethos of CHANGING TOMORROW.
For further information on the company and its people, portfolio and commitments, please visit www.astellas.com